Hyperprogressive disease during PD-1 blockade in patients with advanced pancreatic cancer

The occurrence of markedly accelerated tumor growth during immunotherapy is considered a new mode of progression called hyperprogressive disease (HPD) and its impact on pancreatic cancer (PC) patients receiving immunotherapy is unknown. In this study, we described and explored the incidence, prognos...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shiyun, Han, Lu, Guo, Shiyuan, Tan, Zhaoli, Dai, Guanghai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Immunotherapy - Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486295/
https://www.ncbi.nlm.nih.gov/pubmed/37675466
http://dx.doi.org/10.1080/21645515.2023.2252692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486295/
https://www.ncbi.nlm.nih.gov/pubmed/37675466
http://dx.doi.org/10.1080/21645515.2023.2252692

Ejemplares similares